42 min
Deep Transcranial Magnetic Stimulation (Deep TMS™): BrainsWay’s Innovative and Non-Invasive Therapy for Major Depressive Disorder, Anxious Depression, OCD, and Smoking Addiction LifeSci Partners Podcast
-
- Life Sciences
The CEO of BrainsWay Ltd, Christopher von Jako, is committed to non-invasive medical technologies – particularly when it comes to the brain. A businessman with over 30 years of experience in medical devices and a PhD in neurology, Dr. von Jako now spearheads the continued development, sales, and marketing of BrainsWay’s Deep Transcranial Magnetic Stimulation (Deep TMS™) device, a non-invasive, highly effective, and broadly reimbursed therapy for major depressive disorder, anxious depression, OCD, and smoking addiction. Tune into Episode 58 of the Benchtop Bios Podcast Series, where Dr. von Jako highlights the device, supporting data, and company’s plans for an international rollout.
The CEO of BrainsWay Ltd, Christopher von Jako, is committed to non-invasive medical technologies – particularly when it comes to the brain. A businessman with over 30 years of experience in medical devices and a PhD in neurology, Dr. von Jako now spearheads the continued development, sales, and marketing of BrainsWay’s Deep Transcranial Magnetic Stimulation (Deep TMS™) device, a non-invasive, highly effective, and broadly reimbursed therapy for major depressive disorder, anxious depression, OCD, and smoking addiction. Tune into Episode 58 of the Benchtop Bios Podcast Series, where Dr. von Jako highlights the device, supporting data, and company’s plans for an international rollout.
42 min